Purpose:
This dosimetric study is intended to lower the modulation factor in lung SBRT plans generated in the Eclipse TPS that could replace highly modulated plans that are prone to the interplay effect.
Materials and Methods
Twenty clinical lung SBRT plans with high modulation factors (≥4) were replanned in Varian Eclipse TPS version 15.5 utilizing 2 mm craniocaudal and 1 mm axial block margins followed by light optimization in order to reduce modulation. A Desai et al.1 style optimization, which utilizes a novel shell structure (OptiForR50) for R50% optimization in addition to five consecutive concentric 5 mm shells, was utilized to control dose falloff according to RTOG 0813 & 0915 recommendations. The prescription varied from 34-54 Gy in 1-4 fractions, and the dose objectives were PTV D95% = Rx, PTV Dmax < 140% of Rx, and minimizing the modulation factor. Plan evaluation metrics included modulation factor, CIRTOG, homogeneity index (HI), R50%, D2cm, V105%, and lung V8-12.8Gy (Timmerman Constraint). A random-intercept linear mixed effects model was used with a p≤0.05 threshold to test for statistical significance.
Results
The retrospectively generated plans had significantly lower modulation factors (3.65±0.35 vs 4.59±0.54; p<0.001), lower CIRTOG (0.97±0.02 vs 1.02±0.06; p=0.001), higher HI (1.35±0.06 vs 1.14±0.04; p<0.001), lower R50% (4.09±0.45 vs 4.56±0.56; p<0.001), and lower lungs V8-12.8Gy (Timmerman) (4.61%±3.18% vs 4.92%±3.37%; p<0.001). The high dose spillage V105% was borderline significantly lower (0.44%±0.49% vs 1.10%±1.64%; p=0.051). The D2cm was not statistically different (46.06%±4.01% vs 46.19%±2.80%; p=0.835).
Conclusion
Lung SBRT plans with significantly lower modulation factors can be generated that meet the RTOG constraints, using our planning strategy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.